Skip to main content

toppbild-press-1551x278.jpg

Press

Interview with CEO Peter Wolpert

Link to video »

All pressreleases
Regulatory

2018-09-18 | Press release

Moberg Pharma and Cipher Pharmaceuticals sign exclusive license agreement for MOB-015 in Canada

2018-09-11 | Press release

Moberg Pharma has completed enrollment to Phase 3 study for MOB-015 in North America

2018-08-13 | Press release

Appointment of Chief Medical Officer at Moberg Pharma

2018-09-18 | Press release

Moberg Pharma and Cipher Pharmaceuticals sign exclusive license agreement for MOB-015 in Canada

2018-09-11 | Press release

Moberg Pharma has completed enrollment to Phase 3 study for MOB-015 in North America

2018-08-13 | Press release

Appointment of Chief Medical Officer at Moberg Pharma

Read more press releases »

Latest report

2018-08-07 Moberg Pharma AB interim report January - June 2018

Kontaktperson press och media:

Peter Wolpert, VD
Tel: +46 8 522 307 08
Email: peter.wolpert@mobergpharma.se

Subscribe

Calendar/presentations

Next calendar event: 2018-11-06 Interim report for January - September 2018